Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01335945 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer
A Phase 1 study, sponsored by Boston Scientific Corporation.
- Terminated
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
NCT01335945: Clinical Trial Phase 1 study, sponsored by Boston Scientific Corporation.
NCT01335945 is a Phase 1 study that was terminated before completion, run by Boston Scientific Corporation. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01335945, a Phase 1 study, was terminated before completion, sponsored by Boston Scientific Corporation.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
Study Summary
CUC10-PAN09 will evaluate the safety and efficacy of cryoablation therapy on the relief of epigastric/abdominal pain associated with pancreatic cancer.
Primary Outcome
Measured by the average difference of pre- and post-treatment worst pain in the last 24 hours (baseline), within 24 hours of the cryoablation procedure, 1 week, 4 weeks, 8 weeks and 12 weeks as measured on the numeric 0-10 Brief Pain Inventory (BPI) Scale
Interventions
- PROCEDURE Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2011-08 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Why NCT01335945 stopped before completion
NCT01335945 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Cryoablation is the first listed.
NCT01335945 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01335945 about?
NCT01335945 is a clinical study titled "Safety and Efficacy of Cryoablation for Abdominal Pain Associated With Pancreatic Cancer". CUC10-PAN09 will evaluate the safety and efficacy of cryoablation therapy on the relief of epigastric/abdominal pain associated with pancreatic cancer.
What is the current status of trial NCT01335945?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2011-08. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01335945?
The interventions under investigation include: Cryoablation (PROCEDURE).
Who is sponsoring clinical trial NCT01335945?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01335945's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia